Finally, A Weight Loss Solution for 2018!

Posted on Mon, 18 Dec 2017 

Do you ever get the feeling that small increases in your weight have been sneaking up on you? Those tiny changes over the years may be setting you on a path that is unhealthy. While battling obesity can be daunting understanding how weight is categorized may be helpful in identifying where you are on this path.  Statistics Canada gathers its data using Body Mass Index (BMI), a measure that considers height and weight. BMI is defined as weight in kilograms divided by the square of the height in meters. Those who are 5'4", for example, are considered obese if they weigh over 174.4 pounds. People who are six feet tall are said to be obese if they tip the scales at over 220.7 pounds. Statistics Canada, reports that 1 in 4 adult Canadians and 1 in 10 children have clinical obesity, meaning six million Canadians are currently living with obesity.

Obesity is considered a chronic and progressive condition, like diabetes or high blood pressure and is characterized by excess body fat.  In Canada, obesity rates have tripled between 1985 and 2011. Dr. L.K. Twells, from Memorial University in St. John's, projects that about 21 per cent of Canadian adults will be obese by 2019. The Canadian Obesity Network, and the Canadian Medical Association consider obesity to be a chronic disease. 

The World Health Organization and Health Canada use guidelines based on BMI, calculated for the population aged over 18, excluding pregnant women, and persons less than 3 feet (0.914 meters) tall or greater than 6 feet 11 inches (2.108 meters). Normal weight is classified as BMI 18.5 to 24.9, overweight as BMI 25 to 29.9 and obese as BMI greater than 30. There are 3 different classes of obesity: class 1, BMI 30- 34.9, class 2, BMI 35-39.9 and class 3, BMI over 40. Massive increases in the extreme ends of the obesity spectrum are concerning. Overweight and obesity classifications are associated with an increased risk of dyslipidemia, hypertension, coronary heart disease, Type II diabetes, metabolic syndrome, congestive heart failure, osteoarthritis, specific cancers, sleep apnea, respiratory disorders, gallstones and depression.

Since the development of chronic diseases, such as cardiovascular disease and type II diabetes, is associated with a BMI greater than 25.00 kg/m2, it is critical for health improvements to be introduced prior to reaching clinical obesity. Lifestyle modifications, such as improved diet and increased exercise, are recommended but may be insufficient to address weight issues and challenging to maintain over the long-term. Supplements specifically designed to promote weight and fat loss with a healthy and active lifestyle are needed and being researched. Such products have high protein, high fiber, low carbohydrate and should contain a proprietary blend of vitamins, minerals, antioxidants, phytonutrients, and pre- and pro-biotics, supporting health while facilitating weight loss. Protein and fiber, have evidence to show that they promote satiety and improve appetite ratings. Improved satiety and decreased feelings of hunger may facilitate weight loss along with nutrition counseling and a diet plan.

KGK Science Inc. in London, has offered expert assistance through human clinical trials since 1997. They are currently conducting a clinical study to evaluate a supplement on weight and fat loss in healthy overweight and obese adults. The study offers free nutrition counseling, a complimentary Magic BulletTM and individualized diet plan.  KGK’s clinical trials are conducted under the direction of a Medical Director and Principal Investigator. All studies are reviewed by an independent ethics review board, Health Canada and follow Good Clinical Practice. We are currently looking for participants who would be interested in being a part of this exciting new research.

All records relating to your identity and study participation are confidential as required by the Personal Information Protection and Electronic Documents Act. Each study has its own guidelines – eligibility criteria. To ensure the strongest results, researchers want study participants to be alike in key ways. Examples of eligibility criteria for a treatment trial might be age, gender, and/or your previous medical history.

To participate in KGK Science Inc.’s clinical research on a weight supplement you must be male or female, between the ages of 25-50 and are overweight or obese. Additional information will be determined upon telephone screening. There are no out-of-pocket expenses for you to join this clinical trial, other than your travel expenses to and from the clinic site. Parking at One London Place will be validated, and participants will be compensated up to $450 for their time.

‹ Back